07/07/2025
Scientists from around the world joined to celebrate the illustrious career of Jaroslav Jelinek, MD, PhD, on his retirement as Coriell's Chief Scientific Officer.
Throughout his career, Dr. Jelinek has been a prolific researcher, significantly contributing to understanding cancer biology and hematopoietic stem cells. Over the course of his career, he has published over 120 peer-reviewed articles that have been cited more than 14,000 times. His most-cited article, Dnmt3a Is Essential for Hematopoietic Stem Cell Differentiation, has been cited 1,374 times since its publication in 2012.
Just as important, throughout his career at MD Anderson, the Fels Institute and Coriell, Dr. Jelinek helped mold future generations of biomedical professionals, mentoring dozens of post-docs who cite his tutelage as a significant reason for their successful careers as researchers, professors and clinicians.
On behalf of the biomedical community, we thank Dr. Jelinek for his many contributions to improving human health and fostering a pipeline of top-flight talent to carry on this important work.
We at Coriell wish Jaroslav a long and enjoyable retirement. We will miss his leadership, counsel and good humor.